Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction

The wearable cardioverter–defibrillator (WCD) is used in patients with newly diagnosed heart failure and reduced ejection fraction (HFrEF). In addition to arrhythmic events, the WCD provides near-continuous telemetric heart failure monitoring. The purpose of this study was to evaluate the clinical r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hillmann, Henrike Aenne Katrin, Hohmann, Stephan, Mueller-Leisse, Johanna, Zormpas, Christos, Eiringhaus, Jörg, Bauersachs, Johann, Veltmann, Christian, Duncker, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659567/
https://www.ncbi.nlm.nih.gov/pubmed/34883802
http://dx.doi.org/10.3390/s21237798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659567/
https://www.ncbi.nlm.nih.gov/pubmed/34883802
http://dx.doi.org/10.3390/s21237798

Ejemplares similares